'It's like having half a sugar when you were used to three' - Drug injectors' views and experiences of substitute drug prescribing inside English prisons

International Journal of Drug Policy

Volumn 10, Issue 6, 2000, Pages 455-466

  Hughes, Rhidian A ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Drug injectors; Experiences; Health policy; Prisons; Qualitative research; Substitute prescribing; Views

Indexed keywords

BUPRENORPHINE; LOFEXIDINE; METHADONE;

DRUG CHOICE; DRUG DEPENDENCE TREATMENT; HUMAN; NARCOTIC DEPENDENCE; PRESCRIPTION; PRIORITY JOURNAL; PRISON; REVIEW; SUBSTITUTION THERAPY;

EID: 0033975738     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3959(99)00039-0     Document Type: Review

References (59)

1. Advisory Council on the Misuse of Drugs, 1996. Drug Misusers and the Criminal Justice System, Part III: Drug Misusers and the Prison System - An Integrated Approach. HM Stationery Office, London.
2. Bearn J., Gossop M., Strang J. Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal. Drug Alcohol Depend. 43(1-2):1996;87-91.
3. Bell J., Digiusto E., Byth K. Who should receive methadone maintenance? Br. J. Addict. 87(5):1992;689-694.
4. Biernacki P., Waldorf D. Snowball sampling: problems and techniques of chain referral sampling. Sociol. Methods Res. 10(2):1981;141-163.
5. British Medical Association, 1997. The Misuse of Drugs. Harwood Academic Publishers, Amsterdam.
6. Brooke D., Taylor C., Gunn J., Maden A. Substance misusers remanded to prison - a treatment opportunity? Addiction. 93(12):1998;1851-1856.
7. Caplehorn J.R.M., Hartel D.M., Irwig L. Measuring and comparing the attitudes and beliefs of staff working in New York methadone maintenance clinics. Subst. Use Misuse. 32(4):1997;399-413.
8. Carvel A.L.M., Hart G.J. Risk behaviours for HIV infection among drug users in prison. Br. Med. J. 300(6736):1990;1383-1384.
9. Cavadino M., Dignan J. The Penal System: An Introduction. 2nd ed. 1997;Sage, London.
10. Council of Europe, 1995. Prison and Criminological Aspects of the Control of Transmissible Diseases Including Aids and Related Health Problems in Prisons: Recommendation No. R (93) 6 and Explanatory Report. Council of Europe Press, Strasbourg.
11. Daunno T., Vaughn T.E. Variations in methadone treatment practices: results from a national study. J. Am. Med. Assoc. 267(2):1992;253-258.
12. Dolan K., Wodak A. An international review of methadone provision in prisons. Addict. Res. 4(1):1996;85-97.
13. Dolan K., Hall W., Wodak A. Methadone maintenance reduces injecting in prison (letter). Br. Med. J. 312(7039):1996;1162.
14. Dolan K.A., Wodak A.D., Hall W.D. Methadone maintenance treatment reduces heroin injection in New South Wales prisons. Drug Alcohol Rev. 17(2):1998;153-158.
15. Dyer C. English prison doctor struck off. Br. Med. J. 318(7182):1999;485.
16. Furnham A., Thomson L. Lay theories of heroin addiction. Soc. Sci. Med. 43(1):1996;29-40.
17. Gore S.M., Bird A.G. Drugs in British prisons. Br. Med. J. 316(7140):1998;1256-1257.
18. Hartel D.M., Schoenbaum E.E., Selwyn P.A., Kline J., Davenny K., Klien R.S., Friedland G.H. Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use. Am. J. Public Health. 85(1):1995;83-88.
19. HM Government, 1995. Tackling Drugs Together: A Strategy for England 1995-98 (Cm 2846). HM Stationery Office, London.
20. HM Government, 1998. Tackling Drugs to Build a Better Britain: The Government's 10-Year Strategy for Tackling Drug Misuse (Cm 3945). Stationery Office, London.
21. HM Inspectorate of Prisons for England and Wales, 1996. Patient or Prisoner? A New Strategy for Health Care in Prisons (Discussion Paper). Home Office, London.
22. HM Inspectorate of Prisons for England and Wales, 1998. Report of Her Majesty's Chief Inspector of Prisons. Stationery Office, London.
23. HM Prison Service, 1995. Drug Misuse in Prison. HM Prison Service, London.
24. HM Prison Service, 1996. Health Care Standards for Prisons in England and Wales. HM Prison Service, London.
25. HM Prison Service, 1998. Tackling Drugs in Prison: The Prison Service Drug Strategy. HM Prison Service, London.
26. HM Prison Service and National Health Service Executive, 1999. The Future Organisation of Prison Health Care. Department of Health, London.
27. Hough, M., 1996. Drug Misuse and the Criminal Justice System. Home Office Drugs Prevention Initiative, London.
28. Johnson J.L. Generalizability in qualitative research: excavating the discourse. Morse J.M. Completing a Qualitative Project: Details and Dialogue. 1997;191-208 Sage, London.
29. Kennedy D.H., Nair G., Elliot L., Ditton J. Drug misuse and sharing of needles in Scottish prisons. Br. Med. J. 302(6791):1991;1507.
30. Kosten T.R., Rosen M.I., Schottenfeld R., Ziedonis D. Buprenorphine for cocaine and opiate dependence. Psychopharmacol. Bull. 28(1):1992;15-19.
31. Layder D. Sociological Practice: Linking Theory and Social Research. 1998;Sage, London.
32. MacGregor S., Smith L. The English drug treatment system: experimentation or pragmatism? Klingemann H., Hunt G. Drug Treatment Systems in an International Perspective: Drugs, Demons, and Delinquents. 1998;69-80 Sage, London.
33. Maden A., Swinton M., Gunn J. Drug dependence in prisoners. Br. Med. J. 302(6781):1991;880.
34. Marsch L.A. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction. 93(4):1998;515-532.
35. Mason D., Birmingham L., Grubin D. Substance use in remand prisoners: a consecutive case study. Br. Med. J. 315(7099):1997;8-21.
36. McKeganey N., Barnard M. AIDS, Drugs and Sexual Risk: Lives in the Balance. 1992;Open University Press, Buckingham.
37. Meyenberg R., Stöver H., Jacob J., Pospeschill M. Infektionsprophylaxe im Niedersaechsischen Justizvollzug. 1997;BIS-Verlag, Oldenburg.
38. Miles M.B., Huberman A.M. Qualitative Data Analysis: An Expanded Sourcebook. 2nd ed. 1994;Sage, London.
39. Morse J.M. Qualitative generalizability. Qualitative Health Res. 9(1):1999;5-6.
40. Neale J. Drug users' views of prescribed methadone. Drugs: Education Prev. Policy. 5(1):1998;33-45.
41. Nelles J., Bernasconi S., Dobler-Mikola A., Kaufman B. Provision of syringes and prescription of heroin in prison: the Swiss experience in the prisons of Hindelbank and Oberschöngrün. Int. J. Drug Policy. 8(1):1997;40-52.
42. Newcombe R. Live and let die: is methodone more likely to kill you than heroin? Druglink. 11(1):1996;9-12.
43. O'Hare, P.A., Newcombe, R., Matthews, A., Buning, E.C. and Drucker, E. (Eds), 1992. The Reduction of Drug-Related Harm. Routledge, London.
44. Qualitative Solutions and Research, QSR, 1997. QSR NUD.IST 4: User Guide, 2nd ed. QSR, Melbourne.
45. Reed J., Lyne M. The quality of health care in prison: results of a year's programme of semistructured inspections. Br. Med. J. 315(7120):1997;1420-1424.
46. Rhodes P., Nocon A. User involvement and the NHS reforms. Health Expectations. 1(2):1998;73-81.
47. Ross M., Grossman A.B., Murdoch S., Bundy R., Golding J., Purchase S., Munyard T., Scott M., Bridger A. Prison: shield from threat, or threat to survival? Prison Serv. J. 99(May):1995;23-28.
48. Ross M.W., Darke S. Mad, bad and dangerous to know: dimensions and measurement of attitudes towards injecting drug users. Drug Alcohol Depend. 30(1):1992;71-74.
49. Schofield J.W. Increasing the generalizability of qualitative research. Hammersley M. Social Research: Philosophy, Politics and Practice. 1993;200-225 Sage in association with the Open University, London.
50. Shewan D., Gemmel M., Davies J.B. Behavioral change amongst drug injectors in Scottish prisons. Soc. Sci. Med. 39(11):1994;1585-1586.
51. Sim J. Medical Power in Prisons: The Prison Medical Service in England 1774-1989. 1990;Open University Press, Buckingham.
52. Smith, R., 1984. Prison Health Care. British Medical Association, London.
53. Strang J., Sheridan J., Barber N. Prescribing injectable and oral methadone to opiate addicts: results from the 1995 national postal survey of community pharmacies in England and Wales. Br. Med. J. 313(7052):1996;270-272.
54. Strang J., Finch E., Hankinson L., Farrell M., Taylor C., Gossop M. Methadone treatment for opiate addiction: benefits in the first month. Addict. Res. 5(1):1997;71-76.
55. Task Force to Review Services for Drug Misusers, 1996. Report of an Independent Review of Drug Treatment in England. Department of Health, London.
56. Turnbull P.J., Stimson G.V., Stillwell G. Drug Use in Prison. 1994;AIDS Education and Research Trust, Horsham.
57. Ward J., Bell J., Mattick R.P., Hall W. Methadone maintenance therapy for opioid dependence: a guide to appropriate use. CNS Drugs. 6(6):1996;440-449.
58. Willis J. Prescribing to addicts. Whynes D.K., Bean P.T. Policing and Prescribing: The British System of Drug Control. 1991;1-14 Macmillan, London.
59. World Health Organization, 1993. World Health Organization Guidelines on HIV Infections and AIDS in Prison. World Health Organization, Geneva.